Cormorant Asset Management, LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cormorant Asset Management, LLC
CIK #0001583977
Sector Form 13F Holdings Cap ($BB) Value ($BB)
MLTX 0.2 0.4
CRBP 0.0 0.1
ACLX 0.8 0.1
PCVX 1.2 0.1
LBPH 0.1 0.1
EYPT 0.3 0.1
CRNX 0.9 0.1
EWTX 0.4 0.1
MRUS 0.9 0.0
BBIO 1.3 0.0
View All
Holdings by Sector ($BB)
5.04.03.02.01.00.02012201620202025
EDGAR Form CIK 2011 - 2024
13F-HR [0001583977]
3 [0001583977]
4 [0001583977]
SC 13D [0001583977]
SC 13G [0001583977]
Form 13D/13G Filer Form 13D/13G Subject Filed
Cormorant Asset Management LP Rapport Therapeutics Inc [2024-06-20]
Cormorant Asset Management LP CytomX Therapeutics Inc [2024-05-13]
Cormorant Asset Management LP TScan Therapeutics Inc [2024-04-29]
Cormorant Asset Management LP Ventyx Biosciences Inc [2024-03-21]
Cormorant Asset Management LP Neurogene Inc [2024-02-14]
Cormorant Asset Management LP Korro Bio Inc [2023-11-16]
Cormorant Asset Management LP VYNE Therapeutics Inc [2023-11-13]
Cormorant Asset Management LP Harpoon Therapeutics Inc [2023-11-06]
Cormorant Asset Management LP Alpine Immune Sciences Inc [2023-10-23]
Cormorant Asset Management LP ALX Oncology Holdings Inc [2023-10-13]
View All
Form 3/4/5 Subject 2011 - 2024
BioAge Labs, Inc.
Cormorant Private Healthcare Fund V LP
Chen Bihua
Cormorant Asset Management, LP
Cormorant Private Healthcare Fund IV LP
Corbus Pharmaceuticals Holdings, Inc.
Cormorant Global Healthcare Master Fund, LP
Cormorant Private Healthcare Fund III LP
Biomea Fusion, Inc.
EyePoint Pharmaceuticals, Inc.
View All
Terms | Privacy | Guide
tony@aum13f.com